Briacell Therapeutics Corp
Change company Symbol lookup
Select an option...
BCTX Briacell Therapeutics Corp
AAPL Apple Inc
BCS Barclays PLC
MOR MorphoSys AG
GBNH Greenbrook TMS Inc
ASTL Algoma Steel Group Inc
REKR Rekor Systems Inc
PRDO Perdoceo Education Corp
SCCC Sachem Capital Corp
CEI Camber Energy Inc
Go

Health Care : Biotechnology | Small Cap Value
Based in Canada
Company profile

BriaCell Therapeutics Corp. is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors. Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is focused on conducting Phase I/IIa clinical trial of Bria-IMT in a combination study with immune checkpoint inhibitors such as the Incyte drugs retifanlimab, an anti-PD-1 antibody similar to pembrolizumab, and epacadostat, an orally bioavailable small-molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1). The Company is also focused on development of Bria-OTS, which is an off-the-shelf personalized immunotherapy based on a patient’s HLA-type. Its other pre- clinical candidates include Bria-Pros, Bria-Lung, Bria-Mel, Bria-TILsRx and others.

Closing Price
$6.08
Day's Change
0.31 (5.37%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.14
Day's Low
5.73
Volume
(Light)
Volume:
208,755

10-day average volume:
475,265
208,755
  • Prev Close
    5.77
  • Today's Open
    5.75
  • Day's Range
    5.73-6.14
  • Avg Vol (10-day)
    475.3K
  • Last (time)
    4:00p ET 07/01/22
  • Last (size)
    25
  • 52-Wk Range
    4.06 - 12.47
    LowHigh
  • (12/01/21 - 05/12/22)
    49.75%
  • 87.2%
  • Market Cap
    94.3M
  • Shares Outstanding
    15.5M
  • -1.21
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 21.00
  • (% of float 06/15/22)
    15.03

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.